Karyopharm Therapeutics Inc.

NASDAQ:KPTI

Biotechnology

Healthcare
$7.01 -3.62%

-$0.34 today

Market cap
$158.87M
Beta
0.82
P/E (TTM)
-1.0
EPS (TTM)
-$8.86
52W Low $3.65High $10.99

Volume 0.67M

Average 0.85M

Balance Sheet

Inspect the capital base behind the business.

Assets

$108.42M

FY 2025 · Annual

-34.1% YoY

Liabilities

$401.34M

FY 2025 · Annual

+14.5% YoY

Equity

-$292.93M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Cash & Equivalents190.46M135.19M52.23M62.48M60.54M
Short-term Investments38.16M142.78M139.21M46.24M3.2M
Net Receivables22.5M47.09M26.96M30.77M26.18M
Inventory4.11M4.22M3.04M4.74M4.04M
Other Current Assets6.35M20.89M12.47M12.28M9.19M
Total Current Assets275.61M350.16M233.92M156.49M103.15M
Property, Plant & Equipment (Net)9.56M7.38M4.88M6.28M4.65M
Goodwill00000
Intangible Assets00000
Long-term Investments0000351K
Tax Assets00000
Other Non-current Assets20.14M633K1.64M1.64M267K
Total Non-current Assets29.7M8.01M6.52M7.93M5.27M
Total Assets305.31M358.17M240.44M164.42M108.42M
Account Payables1.6M2.77M3.12M5.11M4M
Short-term Debt00024.43M21.01M
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities20.37M21.47M18.16M15.56M5.96M
Total Current Liabilities73.72M65.91M69.48M92.26M92.06M
Long-term Debt169.29M170.11M170.92M162.95M205.89M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)000072.34M
Other Non-current Liabilities133M132.72M133.46M88.51M25.32M
Total Non-current Liabilities311.26M308.92M307.17M258.17M309.28M
Total Liabilities384.98M374.83M376.64M350.44M401.34M
Common Stock8K12K12K13K14K
Retained Earnings(1.18B)(1.34B)(1.49B)(1.56B)(1.76B)
Accumulated OCI191K(638K)(161K)(356K)71K
Other Stockholders Equity00000
Minority Interest00000
Total Equity(79.67M)(16.66M)(136.21M)(186.02M)(292.93M)
Total Debt180.58M179.07M177.02M194.52M233.61M
Net Debt(9.88M)43.89M124.79M132.05M173.07M

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$90.8M
Receivables$23.4M
Inventory$3.6M
Other Current$8.5M
Total Current Assets$126.3M
PP&E (Net)$4.5M
Long-term Investments$317.0K
Other Non-current$267.0K
Total Non-current Assets$5.1M
Total Assets$131.4M

Analysis

Selected assets total $131.4M for Latest. The largest visible component is Cash & Equivalents at $90.8M, about 69.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportJul 17, 2026
SC 13G/ASC 13G/A filingJun 5, 2026
8-KCurrent reportMay 28, 2026
S-8S-8 filingMay 27, 2026
S-8S-8 filingMay 27, 2026

How much cash does KPTI have?

Karyopharm Therapeutics Inc. (KPTI) reported $60.54M in cash and equivalents in fiscal 2025.

How much debt does KPTI carry?

Karyopharm Therapeutics Inc. (KPTI) reported $233.61M of total debt, with net debt of $173.07M.